10th Proactive GCP Compliance

10th Proactive GCP Compliance

ExL Pharma 18/03/2019 to 20/03/2019 | USA, The Inn at Penn, a Hilton Hotel, 3600 Sansom Street, Philadelphia, 19104

Now in its tenth year, ExL’s Proactive GCP Compliance conference continues to act as the annual forum for both senior-level clinical quality and clinical operations executives to gather, learn and discuss strategies to achieve and maintain global GCP compliance. Join us to learn how to effectively build quality risk management approaches into your clinical operations to optimize research, maintain GCP compliance, contain costs and ensure patient safety.

URLs:

Brochure: https://go.evvnt.com/340775-2?pid=5657

Tickets: https://go.evvnt.com/340775-3?pid=5657

Prices:

Early Bird Pricing — Register by February 1, 2019 — Conference Only: USD 1795.0

Early Bird Pricing — Register by February 1, 2019 — Conference + 1 Workshop: USD 2095.0

Early Bird Pricing — Register by February 1, 2019 — Conference + 2 Workshops: USD 2395.0

Standard Pricing — Register after February 1, 2019 — Conference Only: USD 1995.0

Standard Pricing — Register after February 1, 2019 — Conference + 1 Workshop: USD 2295.0

Standard Pricing — Register after February 1, 2019 — Conference + 2 Workshops: USD 2595.0

Speakers: Nancy Bitters Interim Head of Inspection Management, Biopharma, Global Research and Development Quality, EMD SERONO/MERCK KGAA, Reetu Dandora Executive Director, Strategic Quality Oversight Lead, MRL QUALITY ASSURANCE, Greg Dombal Chief Operating Officer, HALLORAN CONSULTING GROUP, Jason Donnelly Director, Clinical Quality and Compliance, SCHOLAR ROCK, LLC, Deb Driscoll Vice President, Quality Assurance, MERCK RESEARCH LABS, Celeste M. Gonzalez, B.S., CVT, RQAP-GCP, CCRP Principal Specialist, Clinical Quality Assurance, BOSTON SCIENTIFIC, Jeff Kingsley CEO, IACT HEALTH, Cheryl McCarthy, RQAP-GCP, CQA, CBA Associate Director, RandD Quality and Compliance, BIOGEN, Dawn M. Niccum, M.S., RN, PMP, CCRA, RQAP-GCP Senior Director, Quality Assurance and Compliance, INSEPTION GROUP, Dave Nickerson Head of Clinical Quality Management, EMD SERONO, April Rafkind, M.Sc. Director, Pharma Clinical Quality Assurance, NOVARTIS, Sharon Reinhard, M.S. Clinical Compliance Solutions, Consultant on Assignment, MERCK, Karin Rezzonico Associate Director, Clinical Quality Compliance, INSEPTION GROUP, Joanne Spallone Global Development Quality Audit Head, NOVARTIS, Dan Walsh Director, Clinical Oversight, MYLAN, Michele Weitz Senior Director, GCP Compliance Operations, CLOVIS ONCOLOGY, INC., Steven Whittaker Senior Consultant, THE AVOCA GROUP, Liz Wool President, WOOL CONSULTING GROUP, INC.

Time: 9:00 am to 5:00 pm

more
page up